Our clinically certified AI for skin cancer detection is changing how people access the care they need, when they need it.
DERM is the only Class III CE-marked AI medical device for skin cancer, the same regulatory standard required for devices including pacemakers, backed by the world’s largest real-world evidence base of any autonomous AI medical device.
Deployed in more than 25 NHS trusts.
Over 250,000 patient assessments completed.
Over 25,000 cancers found and validated against histopathology, the diagnostic gold standard.
Trusted by leading healthcare leaders and clinical teams to deliver a safe autonomous clinical-grade skin cancer check in seconds.
DERM, our AI Technology, has been in development for over 15 years and in use across live healthcare settings for over 6 years.
DERM is trained to identify patterns, pigment distribution and structural features to a level that can detect even the earliest signs of skin cancer, and with a precision beyond the human eye.
DERM safely and autonomously discharges low-risk patients at the triage stage, while anyone flagged as higher risk is fast tracked to a specialist – across any pathway, from primary and secondary care to private insurance.
DERM works with a dermascope in a clinical setting.
DERM Zero brings the same technology direct to a smartphone, no dermascope required.
up to 95 % reduction
in urgent face-to-face appointments
99.9 % NPV
for melanoma
98 % sensitivity
to all skin cancers
Independently proven to perform at least as well as a face-to-face dermatologist assessment
We power AI skin cancer detection pathways for world-leading healthcare organisations.
The AI that caught 20,000 cancers in the UK is now certified for use on a standard smartphone
Read moreDERM is the future of skin analysis and skin cancer detection. To be a part of this
new era of healthcare, get in touch today.
